New hope for brain fog in schizophrenia? drug trial targets memory and focus
Symptom relief
Recruiting now
This study tests a new medicine called KYN-5356 to see if it can help with thinking and memory problems in people with schizophrenia. About 150 adults who are stable on their current schizophrenia treatment will take either a low, medium, or high dose of the drug or a placebo for…
Phase: PHASE2 • Sponsor: Kynexis B.V. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC